CROSSAMERICA PARTNERS LP (CAPL) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value (m); Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value 2.53×; Formula and calculation Operating income ÷ reported interest expense..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | (m) | Share-based compensation / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Interest coverage · 12 months | 2.53× | Operating income ÷ reported interest expense. $113.17M ÷ $44.82M ≈ 2.53× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | (m) | |
| Stock-based compensation | 1.65M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 113.17M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | 44.82M USD | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: Reported. Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | $1.65M | $113.17M | $44.82M | (m) | (m) | 2.53× | Reported |
| 2026-03-31 | (m) | (m) | $1.24M | $119.40M | $46.05M | (m) | (m) | 2.59× | Reported |
| 2025-12-31 | (m) | (m) | $1.85M | $97.65M | $48.14M | (m) | (m) | 2.03× | Reported |
| 2025-09-30 | (m) | (m) | $1.73M | $99.92M | $50.60M | (m) | (m) | 1.97× | Reported |
| 2025-06-30 | (m) | (m) | $1.92M | $98.93M | $52.98M | (m) | (m) | 1.87× | Reported |
| 2025-03-31 | (m) | (m) | $2.12M | $85.61M | $54.62M | (m) | (m) | 1.57× | Reported |
| 2024-12-31 | (m) | (m) | $1.51M | $70.56M | $52.32M | (m) | (m) | 1.35× | Reported |
| 2024-09-30 | (m) | (m) | $2.08M | $69.19M | $49.41M | (m) | (m) | 1.40× | Reported |
| 2024-06-30 | (m) | (m) | $2.48M | $66.24M | $45.80M | (m) | (m) | 1.45× | Reported |
| 2024-03-31 | (m) | (m) | $2.67M | $65.92M | $42.27M | (m) | (m) | 1.56× | Reported |
| 2023-12-31 | (m) | (m) | $3.03M | $88.07M | $43.74M | (m) | (m) | 2.01× | Reported |
| 2023-09-30 | (m) | (m) | $2.77M | $86.68M | $43.02M | (m) | (m) | 2.01× | Reported |
| 2023-06-30 | (m) | (m) | $2.46M | $102.18M | $40.81M | (m) | (m) | 2.50× | Reported |
| 2023-03-31 | (m) | (m) | $2.12M | $95.40M | $37.45M | (m) | (m) | 2.55× | Reported |
| 2022-12-31 | (m) | (m) | $2.29M | $96.01M | $32.10M | (m) | (m) | 2.99× | Reported |
| 2022-09-30 | (m) | (m) | $1.82M | $86.67M | $28.28M | (m) | (m) | 3.06× | Reported |
| 2022-06-30 | (m) | (m) | $1.51M | $59.62M | $24.86M | (m) | (m) | 2.40× | Reported |
| 2022-03-31 | (m) | (m) | $1.68M | $46.71M | $21.41M | (m) | (m) | 2.18× | Reported |
| 2021-12-31 | (m) | (m) | $1.31M | $36.13M | $18.24M | (m) | (m) | 1.98× | Reported |
| 2021-09-30 | (m) | (m) | $1.19M | $28.02M | $15.70M | (m) | (m) | 1.79× | Reported |
| 2021-06-30 | (m) | (m) | $878.00K | $39.13M | $14.29M | (m) | (m) | 2.74× | Reported |
| 2021-03-31 | (m) | (m) | $509.00K | $37.30M | $14.54M | (m) | (m) | 2.56× | Reported |
| 2020-12-31 | (m) | (m) | $172.00K | $115.59M | $16.59M | (m) | (m) | 6.97× | Reported |
| 2020-09-30 | (m) | (m) | $782.00K | $116.89M | $19.08M | (m) | (m) | 6.13× | Reported |
| 2020-06-30 | (m) | (m) | $968.00K | $105.55M | $22.09M | (m) | (m) | 4.78× | Reported |
| 2020-03-31 | (m) | (m) | $1.07M | $113.14M | $25.20M | (m) | (m) | 4.49× | Reported |
| 2019-12-31 | (m) | (m) | $1.25M | $43.32M | $27.00M | (m) | (m) | 1.60× | Reported |
| 2019-09-30 | (m) | (m) | $688.00K | $49.38M | $29.62M | (m) | (m) | 1.67× | Reported |
| 2019-06-30 | (m) | (m) | $634.00K | $50.69M | $31.24M | (m) | (m) | 1.62× | Reported |
| 2019-03-31 | (m) | (m) | $640.00K | $35.20M | $32.16M | (m) | (m) | 1.09× | Reported |
| 2018-12-31 | (m) | (m) | $481.00K | $35.01M | $32.87M | (m) | (m) | 1.07× | Reported |
| 2018-09-30 | (m) | (m) | $382.00K | $31.34M | $31.67M | (m) | (m) | 0.99× | Reported |
| 2018-06-30 | (m) | (m) | $394.00K | $29.98M | $30.63M | (m) | (m) | 0.98× | Reported |
| 2018-03-31 | (m) | $2.18B | $1.11M | $34.26M | $29.27M | (m) | 0.05% | 1.17× | Reported |
| 2017-12-31 | (m) | $2.09B | $1.93M | $32.42M | $27.92M | (m) | 0.09% | 1.16× | Reported |
| 2017-09-30 | (m) | $2.04B | $3.22M | $27.48M | $26.95M | (m) | 0.16% | 1.02× | Reported |
| 2017-06-30 | (m) | $1.99B | $3.76M | $25.19M | $25.48M | (m) | 0.19% | 0.99× | Reported |
| 2017-03-31 | (m) | $1.97B | $3.51M | $31.83M | $24.39M | (m) | 0.18% | 1.30× | Reported |
| 2016-12-31 | (m) | $1.87B | $3.93M | $32.17M | $22.76M | (m) | 0.21% | 1.41× | Reported |
| 2016-09-30 | (m) | $1.82B | $3.88M | $33.22M | $21.01M | (m) | 0.21% | 1.58× | Reported |
| 2016-06-30 | (m) | $1.96B | $3.55M | $38.05M | $20.24M | (m) | 0.18% | 1.88× | Reported |
| 2016-03-31 | (m) | $2.10B | $3.46M | $32.37M | $19.28M | (m) | 0.16% | 1.68× | Reported |
| 2015-12-31 | (m) | $2.21B | $5.12M | $26.02M | $18.49M | (m) | 0.23% | 1.41× | Reported |
| 2015-09-30 | (m) | $2.35B | $11.37M | $11.22M | $17.62M | (m) | 0.48% | 0.64× | Reported |
| 2015-06-30 | (m) | $2.55B | $12.79M | $4.82M | $17.91M | (m) | 0.50% | 0.27× | Reported |
| 2015-03-31 | (m) | $2.67B | $13.43M | $2.72M | $16.88M | (m) | 0.50% | 0.16× | Reported |
| 2014-12-31 | (m) | $2.67B | $11.40M | $8.64M | $16.63M | (m) | 0.43% | 0.52× | Reported |
| 2014-09-30 | (m) | $2.57B | $4.49M | $19.93M | $16.85M | (m) | 0.18% | 1.18× | Reported |
| 2014-06-30 | (m) | $2.22B | $4.11M | $18.95M | $15.04M | (m) | 0.18% | 1.26× | Reported |
| 2014-03-31 | (m) | $1.94B | $3.91M | $26.49M | $14.83M | (m) | 0.20% | 1.79× | Reported |
| 2013-12-31 | (m) | $1.93B | $3.14M | $28.50M | $14.18M | (m) | 0.16% | 2.01× | Reported |
| 2013-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARKO Petroleum Corp. (APC) | United States | $0.210B | |
| WORLD KINECT CORP (WKC) | United States | $1.839B | -9.58 |